Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosnodenvir Antiviral Activity in DENV-1 Human Challenge
NCT04480736Phase 2Withdrawn
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2020
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mosnodenvir in dengue fever, sponsored by Janssen Pharmaceutical. Planned start Jul 2020; status: withdrawn.
02
Drugs
mosnodenvir
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT04480736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04480736.